What the Label Doesn't Tell You The Hollow Aisle Prove It
FOLLOW THE MONEY. FOLLOW THE SCIENCE. FOLLOW THE EVIDENCE.
A free, independent, evidence-based reference for dietary supplements.
๐Ÿ“– Investigative Books ๐Ÿ† Top 25: Sales vs. Evidence ๐Ÿ”ฌ Live Product Lookup ๐Ÿ”Ž Search Everything
COLEMAN PUBLISHING  โ€ข  PART OF BROKEN PROMISES HEALTHCARE
The American Supplement Investigation

What does the evidence actually say?

A free, independent, evidence-based reference resource for dietary supplements. Investigate ingredients, doses, clinical evidence, safety, drug interactions, regulatory status, and marketing claims โ€” using peer-reviewed research and authoritative government sources, not marketing copy.

Want the whole story? Read the complete American Supplement Investigation trilogy โ€” free โ†’

Browse by Subject

Explore the Research Library

This investigation isn't one book โ€” it's a growing body of evidence on how the supplement industry works, what the science actually shows, and what's at risk when neither is disclosed.

Every Claim, Documented

Annotated Bibliography

Every GAO report, peer-reviewed trial, and federal source behind the numbers on this site โ€” linked, verified, and organized by topic.

Browse the sources โ†’
Evidence & Claims

How to Read a Health Claim

The Evidence Pyramid, the difference between a mechanism and a result, and why "clinically studied" can mean almost anything.

Read the research guide โ†’
Regulation

The Regulatory Gap

Why a supplement can reach a shelf with no premarket proof of safety or effectiveness โ€” and what the label is and isn't required to say.

Read the research guide โ†’
Risk & Interactions

When Natural Isn't Safe

Documented liver injury, drug interactions, and dose toxicity โ€” the evidence on real, measurable supplement harm.

Read the research guide โ†’
The Business

Who Profits From Belief

Subscription models, affiliate commissions, multi-level marketing, and the vocabulary built to sell science it doesn't have.

Read the research guide โ†’
International Comparison

What Other Countries Do

Canada's licensing model, Australia's tiered evidence system โ€” the working alternatives to the U.S. approach.

Read the research guide โ†’
Market vs. Evidence

The Top 25 Supplements: Sales vs. Science

America's best-selling supplements, ranked, and rated against the actual clinical evidence behind each one.

Read the research guide โ†’
Quick Answers

Frequently Asked Questions

The most common questions people ask about safety, interactions, evidence, regulation, and dosing โ€” answered and sourced.

Read the FAQ โ†’
Search Everything

Look Up a Supplement

Search across all three books, every research guide, the FAQ, and the full bibliography in one place.

Start searching โ†’
Live NIH Data

Product Lookup

Look up any real supplement product's actual label โ€” ingredients and claims โ€” live from the NIH's own database.

Look up a product โ†’
Free Tool

"What Are You Taking?"

A printable medication and supplement reconciliation worksheet โ€” bring it to your next appointment.

Get the worksheet โ†’
The Trilogy

The American Supplement Investigation

Why do millions of Americans spend billions of dollars on supplements whose benefits may be uncertain, whose claims can exceed the evidence, and whose risks are often poorly understood? A three-part investigation follows the evidence from the medicine cabinet to a recommendation for what should change.

Cover of What the Label Doesn't Tell You
Book One ยท The Promise and the Evidence

What the Label Doesn't Tell You

Evidence, anecdote, and the vitamin that reversed a generation of advice

A doctor recommended it. The biology made sense. Then the trial found the opposite. Built around the beta-carotene lung cancer trials of the 1990s, this volume teaches readers to tell a mechanism from a result, and a testimonial from proof โ€” the toolkit for everything that follows.

Cover of The Hollow Aisle
Book Two ยท The Regulatory Gap, Risk, and the Business of Belief

The Hollow Aisle

What the law never required anyone to prove

A supplement can reach your shelf with no premarket safety or efficacy review. This volume follows the label, the marketplace, the documented harms, the dollar, and the vocabulary built to sell science it doesn't have โ€” closing with a practical medication-and-supplement worksheet for your next appointment.

Cover of Prove It
Book Three ยท The Reckoning

Prove It

Chronic disease claims, misinformation, and what should change

The trilogy's final volume applies Books One and Two to real chronic disease claims, the information ecosystem that spreads them, and a set of documented case files โ€” closing with a specific, evidence-based recommendation for what U.S. supplement regulation should actually look like.

Book Three ยท Closing Appendix

What Should Change

A tiered evidence framework modeled on Canada's and Australia's working supplement regulatory systems โ€” not full drug-style approval, and not the status quo.

Read the appendix โ†’
Why This Investigation

Why "The American Supplement Investigation"?

Nearly three in four American adults take a dietary supplement. Most assume โ€” reasonably, given how similar the packaging looks to regulated medicine โ€” that some level of government testing stands behind the claim on the label. In most cases, none does.

This is not an argument that supplements are fraudulent. Some work, for some people, for some purposes, and the evidence for a few is genuinely strong. It is an argument that the confidence with which a product is chosen and the evidence that actually exists for it are, far too often, two very different things.

"I write as an investigator, not an advocate. The most dangerous claims are rarely the obviously false ones. They're the ones that are technically true, biologically plausible, and still misleading."

Drawing on Joy Meier's clinical pharmacy expertise and Robert Coleman's forty years in medicine โ€” sixteen as Director of Clinical Pharmacy Services at the VA Palo Alto Health Care System โ€” this investigation applies the same evidence-based standard as Broken Promises Healthcare to a $60 billion industry most Americans engage with every single day.

How We Source Claims

Every Figure, Sourced

Every factual claim in this investigation is sourced โ€” to peer-reviewed research, federal regulatory documents, or government data. Where a figure is an estimate or a range, we say so. If you believe a citation has been misrepresented, tell us โ€” we want to know.

Robert Coleman
MS Pharm.

Robert W. Coleman, MS Pharm.

Forty years in medicine, sixteen of them as Director of Clinical Pharmacy Services at the VA Palo Alto Health Care System, where he ran medication safety programs for tens of thousands of veterans. His peer-reviewed research spans infectious disease, pharmacokinetics, anticoagulation therapy, and medical informatics. He writes as an investigator, not an advocate.

Joy Meier
Pharm.D.

Joy Meier, Pharm.D.

Bio placeholder โ€” to be supplied by Joy. Suggested elements: clinical background and credentials, current or most recent practice setting, relevant specialization, and how she came to co-author this investigation.

Get in Touch

Questions about the research, the trilogy, or reform collaboration โ€” reach out directly.